Page 62 - Vitamin D and Cancer

2 The Molecular Cancer Biology of the VDR 49

125. Colston K, Colston MJ, Fieldsteel AH, Feldman D (1982) 1, 25-dihydroxyvitamin D3 recep-
tors in human epithelial cancer cell lines. Cancer Res 42:856–859
126. Eelen G et al (2004) Microarray analysis of 1alpha, 25-dihydroxyvitamin D3-treated
MC3T3–E1 cells. J Steroid Biochem Mol Biol 89–90:405–407
127. Akutsu N et al (2001) Regulation of gene expression by 1alpha, 25-dihydroxyvitamin D3
and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma cells.
Mol Endocrinol 15:1127–1139
128. Wang TT et al (2005) Large-scale in silico and microarray-based identification of direct 1,
25-dihydroxyvitamin D3 target genes. Mol Endocrinol 19(11):2685–95
129. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP (1996) Transcriptional activation
of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelo-
monocytic cell line U937. Genes Dev 10:142–153
130. Wang QM, Jones JB, Studzinski GP (1996) Cyclin-dependent kinase inhibitor p27 as a
mediator of the G1-S phase block induced by 1, 25-dihydroxyvitamin D3 in HL60 cells.
Cancer Res 56:264–267
131. Li P et al (2004) p27(Kip1) stabilization and G(1) arrest by 1, 25-dihydroxyvitamin D(3) in
ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase
2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase. J Biol Chem 279:25260–25267
132. Huang YC, Chen JY, Hung WC (2004) Vitamin D(3) receptor/Sp1 complex is required for
the induction of p27(Kip1) expression by vitamin D(3). Oncogene 23(28):4856–61
133. Hengst L, Reed S (1996) Translational control of p27Kip1 accumulation during the cell
cycle. Science 271:1861–1864
134. Jiang F, Li P, Fornace AJ Jr, Nicosia SV, Bai W (2003) G2/M arrest by 1, 25-dihydroxyvita-
min D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic
enhancer. J Biol Chem 278:48030–48040
135. Khanim FL et al (2004) Altered SMRT levels disrupt vitamin D3 receptor signalling in
prostate cancer cells. Oncogene 23:6712–6725
136. Lubbert M et al (1991) Stable methylation patterns of MYC and other genes regulated during
terminal myeloid differentiation. Leukemia 5:533–539
137. Koeffler HP (1983) Induction of differentiation of human acute myelogenous leukemia cells:
therapeutic implications. Blood 62:709–721
138. Studzinski GP, Bhandal AK, Brelvi ZS (1986) Potentiation by 1-alpha, 25-dihydroxyvitamin
D3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea. J Natl Cancer
Inst 76:641–648
139. Lin RJ et al (1998) Role of the histone deacetylase complex in acute promyelocytic leukae-
mia. Nature 391:811–814
140. Song G, Wang L (2008) Transcriptional mechanism for the paired miR-433 and miR-127
genes by nuclear receptors SHP and ERRgamma. Nucleic Acids Res 36:5727–5735
141. Shah YM et al (2007) Peroxisome proliferator-activated receptor alpha regulates a microR-
NA-mediated signaling cascade responsible for hepatocellular proliferation. Mol Cell Biol
27:4238–4247
142. Barbieri CE, Pietenpol JA (2006) p63 and epithelial biology. Exp Cell Res 312:695–706
143. Blackburn AC, Jerry DJ (2002) Knockout and transgenic mice of Trp53: what have we
learned about p53 in breast cancer? Breast Cancer Res 4:101–111
144. Kommagani R, Caserta TM, Kadakia MP (2006) Identification of vitamin D receptor as a
target of p63. Oncogene 25:3745–3751
145. Maruyama R et al (2006) Comparative genome analysis identifies the vitamin D receptor gene
as a direct target of p53-mediated transcriptional activation. Cancer Res 66:4574–4583
146. Lu J et al (2005) Transcriptional profiling of keratinocytes reveals a vitamin D-regulated
epidermal differentiation network. J Invest Dermatol 124:778–785
147. Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG (2001) Autocrine TGFbeta signaling
mediates vitamin D3 analog-induced growth inhibition in breast cells. J Cell Physiol
188:383–393